US Patent Issued to Alnylam Pharmaceuticals on Sept. 16 for "Cell death-inducing DFFA-like effector B (CIDEB) iRNA compositions and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,416,006, issued on Sept. 16, was assigned to Alnylam Pharmaceuticals Inc. (Cambridge, Mass.).

"Cell death-inducing DFFA-like effector B (CIDEB) iRNA compositions and methods of use thereof" was invented by Jeffrey Zuber (Somerville, Mass.), James D. McIninch (Burlington, Mass.), Mark K. Schlegel (Lexington, Mass.), Adam Castoreno (Framingham, Mass.), Lucas Bondurant (Brookline, Mass.) and Dhaval Oza (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the CIDEB gene, as well as methods of inhibiting expression of CIDEB, and methods of treating subjects that would...